We first investigated the efficacy of mIL12 mRNA in a monotherapy and combination setting along with PD-L1 antibody treatment in the well characterized, Yummer 1.7 melanoma and the MC38 colorectal tumor cell lines allografted subcutaneously into flanks of wild-type C57BL/6 mice. The gene discussed is CD274; the disease is melanoma.